Welcome to the ValueWiki OPKO HEALTH INC. (OPK) article! Register for free or click the "edit" link to contribute!

OPKO HEALTH INC. (OPK)

This summary section needs content! Click Here to begin writing.

Have a question about OPKO HEALTH INC.? Ask it on the Message Board or Chat Room

Visit the Apple, Inc. page for an example of a complete article.

Today

Max

Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

11/29/08 9:11 am	OPKO HEALTH, INC. Financials (EDGAR Online Financials)
11/12/08 6:11 am	OPKO HEALTH, INC. Files SEC form 10-Q, Quarterly Report (EDGAR Online)
10/27/08 5:10 am	OPKO HEALTH, INC. Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial Statements and (EDGAR Online)
10/02/08 1:10 pm	Opko acquires rights to anti-inflammatory drug (at bizjournals.com)
10/02/08 12:10 pm	OPKO Acquires Worldwide Ophthalmic Rights to Teva's Budesonide for Inflammatory and Allergic Ocular Conditions (Business Wire)
09/18/08 11:09 pm	Wealth & Wellness (at Forbes.com)
09/17/08 8:09 am	OPKO Health to Present at UBS 2008 Global Life Sciences Conference (Business Wire)
09/02/08 9:09 am	Frost-led group closes on merger (at bizjournals.com)
08/08/08 1:08 pm	OPKO HEALTH, INC. Files SEC form 10-Q, Quarterly Report (EDGAR Online)
06/11/08 3:06 pm	OPKO HEALTH, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)